Á lódáil...
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
BACKGROUND: The objective of this clinical open-label trial was to test the safety, tolerability and efficacy of IGF-1 therapy for autosomal dominant cerebellar ataxia (ADCA) patients. RESULTS: A total of 19 molecularly confirmed patients with SCA3, 1 patient with SCA6 and 6 patients with SCA7 compl...
Na minha lista:
| Foilsithe in: | Cerebellum Ataxias |
|---|---|
| Main Authors: | , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2014
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4552149/ https://ncbi.nlm.nih.gov/pubmed/26331037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40673-014-0013-8 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|